{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:11:03Z","timestamp":1793913063704,"version":"4.8.0"},"reference-count":115,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"St. John Paul II Hospital, Krak\u00f3w","award":["FN15\/2026"],"award-info":[{"award-number":["FN15\/2026"]}]},{"award":["FN15\/2026"],"award-info":[{"award-number":["FN15\/2026"]}],"id":[{"id":"https:\/\/ror.org\/01apd5369","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background and Objectives: Despite the presence of atherosclerosis risk factors and symptoms associated with occlusive atherosclerotic cardiovascular disease (ASCVD), up to 30% of individuals do not present significant atherosclerotic lesions at the point of diagnostic evaluation. Those in whom ASCVD was ruled out once might be believed to be at low risk of future major cerebral and cardiac events (MACCEs). Despite this, they might still have some residual risk for MACCEs. Therefore, in the present study we aimed to evaluate risk factors for atherosclerosis progression to the stage of occlusive arterial disease in patients with cardiovascular risk factors but initially free from significant ASCVD. Materials and Methods: Between March 2012 and February 2014, a total of 686 consecutive patients presenting with clinical suspicion of significant coronary artery disease were evaluated. The actual status of atherosclerosis burden was verified in four major arterial territories (coronary, carotid, renal, lower limb arteries) with the use of angiography, computed tomography and ultrasonography. For the present study purpose, 188 (27.4%) patients were enrolled, in whom significant ASCVD (in any of the examined territories) was ruled out. In all patients, the incidence and severity of atherosclerotic risk factors, carotid intima\u2013media complex thickness (CIMT) and carotid plaque presence were evaluated during first hospital admission. A ten-year follow-up period for a composite endpoint of MACCEs was included. Univariate and multivariate Cox proportional hazard analyses with the Simon\u2013Makuch method for new-onset type 2 diabetes mellitus (T2DM) were performed for MACCEs. Results: MACCEs occurred in 30 (16%) of 188 patients, including 5 cardiovascular deaths, 19 non-fatal myocardial infarctions, and 6 non-fatal ischemic strokes, in a median of 48 (Q1; Q3: 25; 86) months. Univariate Cox proportional hazard analysis revealed that individuals who presented with baseline LDL cholesterol &gt; 3.2 mmol\/L, CIMT &gt; 1 mm, carotid plaque, or experienced new-onset T2DM were predisposed to MACCE with hazard ratios (HRs) of 3.21 (p = 0.003), 3.82 (p = 0.001), 5.41 (p &lt; 0.001), and 36.89 (p &lt; 0.001), respectively. In multivariate Cox analysis, its associations with MACCEs were retained (HRs between 2.19 and 21.47), respectively. Conclusions: Our findings support the need for continued risk factor optimization despite the initial exclusion of obstructive ASCVD. In this study, we identified new-onset T2DM, initial LDL cholesterol, and the presence of subclinical atherosclerosis as risk factors for MACCEs.<\/jats:p>","DOI":"10.3390\/diagnostics16152338","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T05:49:27Z","timestamp":1785131367000},"page":"2338","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Subclinical Atherosclerosis, Hyperlipidemia and New-Onset Diabetes Should Not Be Ignored Despite Initial Angiographic Exclusion of Significant Atherosclerotic Occlusive Arterial Disease"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3539-3629","authenticated-orcid":false,"given":"Magdalena","family":"Wawak","sequence":"first","affiliation":[{"name":"Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, ul. \u015aw. \u0141azarza, 16, 31-530 Krakow, Poland"},{"name":"Department of Cardiac and Vascular Diseases, Institute of Cardiology, Jagiellonian University Medical College, \u015bw. Anny 12, 31-007 Krakow, Poland"},{"name":"Department of Interventional Cardiology, The St. John Paul II Hospital, Pr\u0105dnicka 80, 31-202 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Tekieli","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology, The St. John Paul II Hospital, Pr\u0105dnicka 80, 31-202 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Piechocki","sequence":"additional","affiliation":[{"name":"Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, ul. \u015aw. \u0141azarza, 16, 31-530 Krakow, Poland"},{"name":"Department of Cardiac and Vascular Diseases, The St. John Paul II Hospital, Pr\u0105dnicka 80, 31-202 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Odrow\u0105\u017c-Pieni\u0105\u017cek","sequence":"additional","affiliation":[{"name":"Department of Cardiac and Vascular Diseases, Institute of Cardiology, Jagiellonian University Medical College, \u015bw. Anny 12, 31-007 Krakow, Poland"},{"name":"Department of Interventional Cardiology, The St. John Paul II Hospital, Pr\u0105dnicka 80, 31-202 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Ka\u017anica-Wiatr","sequence":"additional","affiliation":[{"name":"Department of Cardiac and Vascular Diseases, The St. John Paul II Hospital, Pr\u0105dnicka 80, 31-202 Krakow, Poland"},{"name":"Center for Innovative Medical Education, Department of Medical Education, Faculty of Medicine, Jagiellonian University Medical College, 31-008 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Mazur","sequence":"additional","affiliation":[{"name":"Department of Cardiac and Vascular Diseases, The St. John Paul II Hospital, Pr\u0105dnicka 80, 31-202 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Maciak-Paw\u0142ucka","sequence":"additional","affiliation":[{"name":"Department of Cardiac and Vascular Diseases, The St. John Paul II Hospital, Pr\u0105dnicka 80, 31-202 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Komar","sequence":"additional","affiliation":[{"name":"Department of Cardiac and Vascular Diseases, Institute of Cardiology, Jagiellonian University Medical College, \u015bw. Anny 12, 31-007 Krakow, Poland"},{"name":"Department of Cardiac and Vascular Diseases, The St. John Paul II Hospital, Pr\u0105dnicka 80, 31-202 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeusz","family":"Przew\u0142ocki","sequence":"additional","affiliation":[{"name":"Department of Cardiac and Vascular Diseases, Institute of Cardiology, Jagiellonian University Medical College, \u015bw. Anny 12, 31-007 Krakow, Poland"},{"name":"Department of Interventional Cardiology, The St. John Paul II Hospital, Pr\u0105dnicka 80, 31-202 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8006-7840","authenticated-orcid":false,"given":"Anna","family":"Kab\u0142ak-Ziembicka","sequence":"additional","affiliation":[{"name":"Department of Cardiac and Vascular Diseases, Institute of Cardiology, Jagiellonian University Medical College, \u015bw. Anny 12, 31-007 Krakow, Poland"},{"name":"Department of Cardiac and Vascular Diseases, The St. John Paul II Hospital, Pr\u0105dnicka 80, 31-202 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1093\/eurheartj\/ehae466","article-title":"European Society of Cardiology: The 2023 Atlas of Cardiovascular Disease Statistics","volume":"45","author":"Timmis","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Hasani, W.S.R., Muhamad, N.A., Hanis, T.M., Maamor, N.H., Chen, X.W., Omar, M.A., Cheng Kueh, Y., Abd Karim, Z., Hassan, M.R.A., and Musa, K.I. (2023). The global estimate of premature cardiovascular mortality: A systematic review and meta-analysis of age-standardized mortality rate. BMC Public Health, 23.","DOI":"10.1186\/s12889-023-16466-1"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"M\u0142ynarska, E., Czarnik, W., Fularski, P., Hajdys, J., Majchrowicz, G., Stabrawa, M., Rysz, J., and Franczyk, B. (2024). From Atherosclerotic Plaque to Myocardial Infarction\u2014The Leading Cause of Coronary Artery Occlusion. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25137295"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCRESAHA.116.308441","article-title":"Stroke Caused by Atherosclerosis of the Major Intracranial Arteries","volume":"120","author":"Banerjee","year":"2017","journal-title":"Circ. Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Kab\u0142ak-Ziembicka, A., and Przew\u0142ocki, T. (2021). Clinical Significance of Carotid Intima-Media Complex and Carotid Plaque Assessment by Ultrasound for the Prediction of Adverse Cardiovascular Events in Primary and Secondary Care Patients. J. Clin. Med., 10.","DOI":"10.3390\/jcm10204628"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014An Inflammatory Disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.acra.2016.12.005","article-title":"Influence of Cardiovascular Risk Factors on the Prevalence of Coronary Atherosclerosis in Patients with Angiographically Normal Coronary Arteries","volume":"24","author":"Bittner","year":"2017","journal-title":"Acad. Radiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jcmg.2016.02.010","article-title":"Sex-Specific Associations Between Coronary Artery Plaque Extent and Risk of Major Adverse Cardiovascular Events: The CONFIRM Long-Term Registry","volume":"9","author":"Hartaigh","year":"2016","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Castel-Feced, S., Malo, S., Aguilar-Palacio, I., Feja-Solana, C., Casasnovas, J.A., Maldonado, L., and Rabanaque-Hern\u00e1ndez, M.J. (2023). Influence of cardiovascular risk factors and treatment exposure on cardiovascular event incidence: Assessment using machine learning algorithms. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0293759"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/j.jacc.2016.08.069","article-title":"The Risk Continuum of Atherosclerosis and its Implications for Defining CHD by Coronary Angiography","volume":"68","author":"Fuster","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/clc.23686","article-title":"Long-term outcomes in patients with normal coronary arteries, nonobstructive, or obstructive coronary artery disease on invasive coronary angiography","volume":"44","author":"Hanson","year":"2021","journal-title":"Clin. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000087480.94275.97","article-title":"From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part I","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Piechocki, M., Ka\u017anica-Wiatr, M., and Kab\u0142ak-Ziembicka, A. (2025). Prevalence of Carotid Atherosclerotic Plaques and Stenosis in Adults with Familial Hypercholesterolemia Needs Reappraisal: Systematic Review and Meta-Analysis. J. Clin. Med., 14.","DOI":"10.3390\/jcm14248676"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41569-026-01249-z","article-title":"Residual cardiovascular risk in coronary artery disease: From pathophysiology to established and novel therapies","volume":"23","author":"Galli","year":"2026","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wang, C., Fu, H., Xu, H., Yang, H., Min, X., Wu, W., Liu, Z., Li, D., Dong, Y., and Chen, J. (2025). Non-traditional lipid biomarkers in atherosclerotic cardiovascular disease: Pathophysiological mechanisms and strategies to address residual risk. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1576602"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e045382","DOI":"10.1161\/JAHA.125.045382","article-title":"Insomnia, Sleep Apnea, and Incidence of Hypertension and Cardiovascular Disease Among Men and Women US Veterans","volume":"14","author":"Gaffey","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Podolec, J., Kleczy\u0144ski, P., Piechocki, M., Okarski, M., Lizo\u0144czyk, K., Szkodo\u0144, K., Silczuk, A., Przew\u0142ocki, T., Legutko, J., and Kab\u0142ak-Ziembicka, A. (2024). Depression in Cardiac Patients Is a Major Cardiovascular Event Risk Factor: A 12-Month Observational Study. J. Clin. Med., 13.","DOI":"10.3390\/jcm13226911"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Paduraru, L., Zaha, D.C., Ghitea, T.C., Fodor, R., Vesa, C.M., and Popoviciu, M.S. (2025). Integrating Renal and Metabolic Parameters into a Derived Risk Score for Hyperuricemia in Uncontrolled Type 2 Diabetes: A Retrospective Cross-Sectional Study in Northwest Romania. Medicina, 61.","DOI":"10.3390\/medicina61112042"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2147\/VHRM.S37119","article-title":"Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: Relationship with subclinical disease, undertreatment, and poor adherence: Implications of new evidence upon optimizing cardiovascular patient outcomes","volume":"9","author":"Kones","year":"2013","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Badacz, R., Przew\u0142ocki, T., Legutko, J., \u017bmudka, K., and Kab\u0142ak-Ziembicka, A. (2022). microRNAs associated with carotid plaque development and vulnerability: The clinician\u2019s perspective. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415645"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Xu, S.Z., and Sathyapalan, T. (2024). Molecular Aspects of Cardiovascular Risk Factors. Biomolecules, 14.","DOI":"10.3390\/biom14081032"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.14336\/AD.2021.0929","article-title":"The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy","volume":"13","author":"Lu","year":"2022","journal-title":"Aging Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/HCO.0000000000001003","article-title":"Primary prevention statin therapy in older adults","volume":"38","author":"Nanna","year":"2023","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/jgs.18312","article-title":"Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale","volume":"71","author":"Joseph","year":"2023","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e036357","DOI":"10.1161\/JAHA.124.036357","article-title":"Baseline Characteristics of Participants in STAREE: A Randomized Trial for Primary Prevention of Cardiovascular Disease Events and Prolongation of Disability-Free Survival in Older People","volume":"13","author":"Zoungas","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: The European Stroke Organization (ESO). The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Piechocki, M., Przew\u0142ocki, T., Pieni\u0105\u017cek, P., Trystu\u0142a, M., Podolec, J., and Kab\u0142ak-Ziembicka, A. (2024). A Non-Coronary, Peripheral Arterial Atherosclerotic Disease (Carotid, Renal, Lower Limb) in Elderly Patients\u2014A Review: Part II\u2014Pharmacological Approach for Management of Elderly Patients with Peripheral Atherosclerotic Lesions outside Coronary Territory. J. Clin. Med., 13.","DOI":"10.3390\/jcm13051508"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Park, J., Han, K., Lee, K., Chang, Y., and Shin, D.W. (2025). Risk of Cardiovascular Disease According to the Precedence Relationship Between Hypertension and Diabetes Mellitus. Healthcare, 13.","DOI":"10.3390\/healthcare13070796"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.31083\/j.rcm2512436","article-title":"Diabetes Mellitus and Cardiovascular Disease: Exploring Epidemiology, Pathophysiology, and Treatment Strategies","volume":"25","author":"Siam","year":"2024","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000343145","article-title":"Mannheim Carotid Intima-Media Thickness and Plaque Consensus (2004\u20132006\u20132011)","volume":"34","author":"Touboul","year":"2012","journal-title":"Cerebrovasc. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1037\/a0026502","article-title":"The psychological impact of test results following diagnostic coronary CT angiography","volume":"31","author":"Devcich","year":"2012","journal-title":"Health Psychol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12529-015-9531-x","article-title":"Predicting Self-Management Behaviors in Familial Hypercholesterolemia Using an Integrated Theoretical Model: The Impact of Beliefs About Illnesses and Beliefs About Behaviors","volume":"23","author":"Hagger","year":"2016","journal-title":"Int. J. Behav. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.120.316101","article-title":"Obesity Phenotypes, Diabetes, and Cardiovascular Diseases","volume":"126","author":"Tchernof","year":"2020","journal-title":"Circ. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"100116","DOI":"10.1016\/j.ajpc.2020.100116","article-title":"Progression of coronary atherosclerosis in patients without standard modifiable risk factors","volume":"4","author":"Mazhar","year":"2020","journal-title":"Am. J. Prev. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa2405182","article-title":"Inflammation, cholesterol, lipoprotein(a), and 30-year cardiovascular outcomes in women","volume":"391","author":"Ridker","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Global Cardiovascular Risk Consortium, Magnussen, C., Alegre-Diaz, J., Al-Nasser, L.A., Amouyel, P., Aviles-Santa, L., Bakker, S.J.L., Ballantyne, C.M., Bernab\u00e9-Ortiz, A., and Bobak, M. (2025). Global Effect of Cardiovascular Risk Factors on Lifetime Estimates. N. Engl. J. Med., 393, 125\u2013138.","DOI":"10.1056\/NEJMoa2415879"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Liao, Y.P., Wei, Y.X., Zhang, F.M., Zhang, Z.S., Xu, S.P., You, Y.H., and Guo, J.W. (2026). The cardiovascular-immune axis: Crosstalk and therapy in atherosclerosis, myocarditis and vasculitis. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1781248"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Przytu\u0142a, N., Podolec, J., Przew\u0142ocki, T., Podolec, P., and Kab\u0142ak-Ziembicka, A. (2025). Inflammasomes as Potential Therapeutic Targets to Prevent Chronic Active Viral Myocarditis\u2014Translating Basic Science into Clinical Practice. Int. J. Mol. Sci., 26.","DOI":"10.20944\/preprints202509.1796.v1"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/imj.70341","article-title":"Statin deprescribing: A comprehensive review and development of a clinical algorithm for optimal patient management","volume":"56","author":"Lupi","year":"2026","journal-title":"Intern. Med. J."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Bui, L., Le, T.T., Dao, N.H., Nguyen, H.T., Nguyen, T.T., Pham, V.T.T., Cao, T.T.B., Nguyen, P.T., and Dong, P.T.X. (2026). Statin prescribing patterns in cardiovascular risk management among outpatients with type 2 diabetes: Real-world practices at a Vietnamese general hospital. PLoS ONE, 21.","DOI":"10.1371\/journal.pone.0343313"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.18773\/austprescr.2024.023","article-title":"Deprescribing antihypertensive drugs in frail older adults","volume":"47","author":"Reeve","year":"2024","journal-title":"Aust. Prescr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jpsychores.2008.07.003","article-title":"Psychological responses to cardiac diagnosis: Changes in illness representations immediately following coronary angiography","volume":"65","author":"Devcich","year":"2008","journal-title":"J. Psychosom. Res."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Thagizadeh, A., Ghahramanian, A., Zamanzadeh, V., Aslanabadi, N., Onyeka, T.C., and Ramazanzadeh, N. (2022). Illness perception and cardiovascular risk factors in patients with myocardial infarction undergoing percutaneous coronary intervention in Iran. BMC Cardiovasc. Disord., 22.","DOI":"10.1186\/s12872-022-02684-9"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.atherosclerosis.2018.06.010","article-title":"Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia","volume":"277","author":"Hagger","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCGENETICS.116.001381","article-title":"Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States","volume":"9","author":"deGoma","year":"2016","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2513434","DOI":"10.1080\/08037051.2025.2513434","article-title":"Patient perceptions, motivations and barriers to treatment adherence in hypertension: Results of a questionnaire-based survey in five European countries","volume":"34","author":"Burnier","year":"2025","journal-title":"Blood Press."},{"key":"ref_52","first-page":"401","article-title":"Repeat coronary angiography with previously normal arteries: A futile exercise?","volume":"85","author":"Rowe","year":"2015","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ahj.2013.07.030","article-title":"Predictors of normal coronary arteries at coronary angiography","volume":"166","author":"Levitt","year":"2013","journal-title":"Am. Heart J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"B68","DOI":"10.1016\/j.jacc.2015.08.196","article-title":"TCT-183 Repeat Coronary Angiography in Patients with Previously Normal Coronary Arteries","volume":"66","author":"Androshchuk","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Roguin, A., Kobo, O., Meisel, S.-R., Darawsha, Z., Odeh, M., Frimerman, A., Amsalem, N., and Abu Fanne, R. (2024). Repeat Coronary Angiography in Patients Aged over 50 Years with Previously Normal\/Non-Obstructive Coronary Angiogram\u2014Insights from a Retrospective Study. J. Clin. Med., 13.","DOI":"10.3390\/jcm13030870"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e042858","DOI":"10.1161\/JAHA.125.042858","article-title":"Identification of Clinical Phenotypes in Type 2 Myocardial Infarction: Insights Into Characteristics, Prognosis, and Management Strategies","volume":"14","author":"Bertolini","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jacc.2021.05.011","article-title":"Progression of Early Subclinical Atherosclerosis (PESA) Study: JACC Focus Seminar 7\/8","volume":"78","author":"Ibanez","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"kyag014","DOI":"10.1093\/discim\/kyag014","article-title":"Distinct lipid transport proteins are regulated by innate immune stimuli","volume":"5","author":"Tsamouri","year":"2026","journal-title":"Discov. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-nutr-081810-160756","article-title":"The role of microRNAs in cholesterol efflux and hepatic lipid metabolism","volume":"31","author":"Moore","year":"2011","journal-title":"Annu. Rev. Nutr."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/ATVBAHA.114.304723","article-title":"Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of MicroRNA-155 on atherosclerosis","volume":"35","author":"Wei","year":"2015","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Kab\u0142ak-Ziembicka, A., Badacz, R., and Przew\u0142ocki, T. (2022). Clinical Application of Serum microRNAs in Atherosclerotic Coronary Artery Disease. J. Clin. Med., 11.","DOI":"10.3390\/jcm11226849"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5551\/jat.RV22045","article-title":"Critical Role of microRNA-33a\/b in Cardiovascular and Metabolic Disease: Molecular Mechanisms and Therapeutic Perspectives","volume":"33","author":"Horie","year":"2026","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.celrep.2017.10.023","article-title":"Genetic Dissection of the Impact of miR-33a and miR-33b during the Progression of Atherosclerosis","volume":"21","author":"Price","year":"2017","journal-title":"Cell Rep."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Wang, Y., Zhang, Z., Ren, W., Shi, L., Zhai, T., and Huang, J. (2025). Liver function differences in atherosclerotic cardiovascular disease: A multi-ethnic dual-cohort retrospective study. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1558872"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Kalwick, M., and Roth, M. (2025). A Comprehensive Review of the Genetics of Dyslipidemias and Risk of Atherosclerotic Cardiovascular Disease. Nutrients, 17.","DOI":"10.3390\/nu17040659"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.atherosclerosis.2020.07.006","article-title":"Long Term Follow-up of Genetically Confirmed Patients with Familial Hypercholesterolemia Treated with First and Second-Generation Statins and Then with PCSK9 Monoclonal Antibodies","volume":"308","author":"Pasta","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJMoa064278","article-title":"Treating to New Targets Investigators HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events","volume":"357","author":"Barter","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.amjcard.2010.05.002","article-title":"Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control","volume":"106","author":"Carey","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"100701","DOI":"10.1016\/j.ajpc.2024.100701","article-title":"Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyond","volume":"19","author":"Safarova","year":"2024","journal-title":"Am. J. Prev. Cardiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1001\/jama.2026.3277","article-title":"Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV Trial","volume":"335","author":"Marston","year":"2026","journal-title":"JAMA"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Ala\u00edz, \u00c1.R., Gudino, L.C., de la Isla, L.P., Pardo, H.G., Calle, D.G., and Miramontes-Gonz\u00e1lez, J.P. (2025). Inclisiran: Efficacy in Real World\u2014Systematic Review and Meta-Analysis. J. Clin. Med., 14.","DOI":"10.3390\/jcm14124163"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/14779072.2023.2288169","article-title":"PCSK9 inhibitors: Current status and emerging frontiers in lipid control","volume":"22","author":"Agnello","year":"2024","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"106442","DOI":"10.1016\/j.ejim.2025.106442","article-title":"Optimizing PCSK9 inhibitor therapy: Understanding and managing suboptimal LDL-C response in clinical practice","volume":"140","author":"Pellin","year":"2025","journal-title":"Eur. J. Intern. Med."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Brie, D.M., Morno\u0219, C., Adam, O., T\u00eerziu, A., Popescu, R., and Brie, A.D. (2026). Inflammatory Mechanisms in Acute Coronary Syndromes: From Pathophysiology to Therapeutic Targets. Cells, 15.","DOI":"10.3390\/cells15010072"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Silva, G.L.R., Sposito, A.C., Coelho-Filho, O., and Quinaglia, T. (2026). Cardiovascular risk stratification in inflammatory-driven conditions: How far have we come?. Front. Cardiovasc. Med., 13.","DOI":"10.3389\/fcvm.2026.1601800"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/cvr\/cvae240","article-title":"Inflammageing, a targetable pathway for preventing cardiovascular diseases","volume":"121","author":"Aranda","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Poznyak, A.V., Sadykhov, N.K., Kartuesov, A.G., Borisov, E.E., Melnichenko, A.A., Grechko, A.V., and Orekhov, A.N. (2022). Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.959285"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40885-023-00258-1","article-title":"Arterial stiffness and hypertension","volume":"29","author":"Kim","year":"2023","journal-title":"Clin. Hypert."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"M\u00e9ndez-Barbero, N., Guti\u00e9rrez-Mu\u00f1oz, C., and Blanco-Colio, L.M. (2021). Cellular Crosstalk between Endothelial and Smooth Muscle Cells in Vascular Wall Remodeling. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147284"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Piechocki, M., Przew\u0142ocki, T., Pienia\u017cek, P., Trystu\u0142a, M., Podolec, J., and Kab\u0142ak-Ziembicka, A. (2024). A Non-Coronary, Peripheral Arterial Atherosclerotic Disease (Carotid, Renal, Lower Limb) in Elderly Patients\u2014A Review: Part I\u2014Epidemiology, Risk Factors, and Atherosclerosis-Related Diversities in Elderly Patients. J. Clin. Med., 13.","DOI":"10.3390\/jcm13051471"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/HYPERTENSIONAHA.120.16667","article-title":"Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study","volume":"78","author":"Chen","year":"2021","journal-title":"Hypertension"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"The Prevention of Dementia with Antihypertensive Treatment: New Evidence from the Systolic Hypertension in Europe (Syst-Eur) Study","volume":"162","author":"Forette","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCULATIONAHA.121.054602","article-title":"Harmonization of the American College of Cardiology\/American Heart Association and European Society of Cardiology\/European society of hypertension blood pressure\/hypertension guidelines: Comparisons, reflections, and recommendations","volume":"146","author":"Whelton","year":"2022","journal-title":"Circulation"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s40292-019-00336-2","article-title":"Treatment with Free Triple Combination Therapy of Atorvastatin, Perindopril, Amlodipine in Hypertensive Patients: A Real-World Population Study in Italy","volume":"26","author":"Perrone","year":"2019","journal-title":"High Blood Press. Cardiovasc. Prev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s40520-024-02879-4","article-title":"A newly developed method for assessing co-exposure to free dose combinations: A proof-of-concept study using antihypertensive medications in Danish registers","volume":"36","author":"Barbieri","year":"2024","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5847\/wjem.j.1920-8642.2011.01.004","article-title":"Five-year mortality and coronary heart disease development after normal coronary angiogram","volume":"2","author":"McMullan","year":"2011","journal-title":"World J. Emerg. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/eurheartj\/ehab600","article-title":"Atherothrombotic factors and atherosclerotic cardiovascular events: The multi-ethnic study of atherosclerosis","volume":"43","author":"DeFilippis","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/jdi.70006","article-title":"A systematic analysis and prediction of the disease burden of ischemic heart disease caused by hyperglycemia","volume":"16","author":"Chen","year":"2025","journal-title":"J. Diabetes Investig."},{"key":"ref_89","first-page":"62","article-title":"The interplay between diabetes and atherosclerosis: A review of pathophysiological mechanisms","volume":"21","author":"Cheraghi","year":"2025","journal-title":"ARYA Atheroscler. J."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Zhou, M., Liu, L., Sun, Y., and Wang, X. (2025). Lactylation in diabetes mellitus and its complications: Mechanisms of action and therapeutic potential\u2014recent advances. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1710645"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Luo, S., Wang, Y., Luo, Z., Dai, A., and Dai, Q. (2025). Lactylation in Vascular Diseases: A Double-Edged Sword. Cells, 14.","DOI":"10.3390\/cells14241987"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Foroshani, S., Tang, K.S., and Wong, N.D. (2026). Frailty and Cardiometabolic Outcomes: A Narrative Review. J. Clin. Med., 15.","DOI":"10.3390\/jcm15041348"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Badacz, R., Przew\u0142ocki, T., Pieni\u0105\u017cek, P., Ros\u0142awiecka, A., Kleczy\u0144ski, P., Legutko, J., \u017bmudka, K., and Kab\u0142ak-Ziembicka, A. (2022). MicroRNA-134-5p and the Extent of Arterial Occlusive Disease Are Associated with Risk of Future Adverse Cardiac and Cerebral Events in Diabetic Patients Undergoing Carotid Artery Stenting for Symptomatic Carotid Artery Disease. Molecules, 27.","DOI":"10.3390\/molecules27082472"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"24","DOI":"10.55729\/2000-9666.1563","article-title":"Statin Induced New-onset Diabetes Mellitus\u2014A Narrative Review","volume":"16","author":"Manha","year":"2026","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1038\/s41598-024-84985-x","article-title":"Contribution of type 2 diabetes to major adverse cardiovascular events (MACE) in a long-term observational study with different stages of atherosclerosis","volume":"15","author":"Mader","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40101-024-00365-4","article-title":"Sustained metabolic dysregulation and the emergence of diabetes: Associations between HbA1c and metabolic syndrome components in Tunisian diabetic and nondiabetic groups","volume":"43","author":"Wisniewski","year":"2024","journal-title":"J. Physiol. Anthropol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Popoviciu, M.S., Pop, A.M., Ghitea, T.C., Dorobantu, F.R., Pantis, C., Pop, N.O., and Brata, R.D. (2026). HbA1c as a Continuous Marker of Microvascular Vulnerability: Development of a Non-Linear Risk Framework in a Real-World Cohort. Metabolites, 16.","DOI":"10.3390\/metabo16030197"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"100371","DOI":"10.1016\/j.ajpc.2022.100371","article-title":"There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness","volume":"12","author":"Makover","year":"2022","journal-title":"Am. J. Prev. Cardiol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Le, R., Nguyen, M.T., Allahwala, M.A., Psaltis, J.P., Marathe, C.S., Marathe, J.A., and Psaltis, P.J. (2024). Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs. J. Clin. Med., 13.","DOI":"10.3390\/jcm13164674"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"117515","DOI":"10.1016\/j.atherosclerosis.2024.117515","article-title":"Subclinical atherosclerosis in young adults predicting cardiovascular disease: The Cardiovascular Risk in Young Finns Study","volume":"393","author":"Raitakari","year":"2024","journal-title":"Atherosclerosis"},{"key":"ref_101","first-page":"1024","article-title":"Relationship between carotid intima-media thickness, cytokines, atherosclerosis extent and a two-year cardiovascular risk in patients with arteriosclerosis","volume":"69","author":"Sliwiak","year":"2011","journal-title":"Kardiol. Pol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"103","DOI":"10.31083\/j.rcm2503103","article-title":"Impact of Classical Risk Factors on Subclinical Carotid Atherosclerosis Progression: Insights from a Non-Diabetic Cohort","volume":"25","author":"Lisovszki","year":"2024","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"101011","DOI":"10.1016\/j.ajpc.2025.101011","article-title":"Carotid intima-media thickness, cardiovascular disease, and risk factors in 29,000 UK Biobank adults","volume":"22","author":"Mitra","year":"2025","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Dzenkeviciute, V., Adomavicius, T., Tarutyte, G., Rinkuniene, E., Kasiulevicius, V., and Badariene, J. (2026). Carotid Plaques and Type 2 Diabetes as Predictors of Cardiovascular Events and Mortality: Insights from the LitHiR Prospective Cohort Study. J. Clin. Med., 15.","DOI":"10.3390\/jcm15145695"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.atherosclerosis.2009.08.019","article-title":"The role of carotid intima-media thickness assessment in cardiovascular risk evaluation in patients with polyvascular atherosclerosis","volume":"209","author":"Przewlocki","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Zambrzycki, B., \u0141uczaj, M., Dubat\u00f3wka, M., Da\u0144kowska, K., Nowicka, K., Knapp, M., Szpakowicz, A., Kami\u0144ski, K., and Lisowska, A. (2024). Identifying Risk Factors for Lower Extremity Artery Disease (LEAD) in Cardiology Patients: The Role of Ankle-Brachial Index Measurement. J. Clin. Med., 13.","DOI":"10.3390\/jcm13247858"},{"key":"ref_107","first-page":"808","article-title":"Prospective study on the prognostic value of repeated carotid intima-media thickness assessment in patients with coronary and extra coronary steno-occlusive arterial disease","volume":"129","author":"Podolec","year":"2019","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/CIRCULATIONAHA.120.046361","article-title":"Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients","volume":"142","author":"Willeit","year":"2020","journal-title":"Circulation"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jacc.2024.06.045","article-title":"Influence of Subclinical Atherosclerosis Burden and Progression on Mortality","volume":"84","author":"Fuster","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Bekbossynova, M., Saliev, T., Ivanova-Razumova, T., Andossova, S., Kali, A., and Myrzakhmetova, G. (2025). Beyond Cholesterol: Emerging Risk Factors in Atherosclerosis. J. Clin. Med., 14.","DOI":"10.3390\/jcm14072352"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Tsioulos, G., Kounatidis, D., Vallianou, N.G., Poulaki, A., Kotsi, E., Christodoulatos, G.S., Tsilingiris, D., Karampela, I., Skourtis, A., and Dalamaga, M. (2024). Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063537"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.atherosclerosis.2010.10.017","article-title":"Carotid intima-media thickness, hs-CRP and TNF-\u03b1 are independently associated with cardiovascular event risk in patients with atherosclerotic occlusive disease","volume":"214","author":"Tracz","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Tao, L.V., Karasinska, J.M., Souza, V.G.P., Loree, J.M., Johnson, J.D., Renouf, D.J., and Schaeffer, D.F. (2026). New-onset diabetes as an emerging risk group for early detection of pancreatic cancer: Current evidence, clinical challenge, and future directions. Front. Gastroenterol., 4.","DOI":"10.3389\/fgstr.2025.1645459"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1583\/11-3805R.1","article-title":"Zotarolimus-eluting stent for the treatment of recurrent, severe carotid artery in-stent stenosis in the TARGET-CAS population","volume":"19","author":"Tekieli","year":"2012","journal-title":"J. Endovasc. Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1093\/eurheartj\/ehaf304","article-title":"Adult-onset type 1 diabetes: Predictors of major cardiovascular events and mortality","volume":"46","author":"Wei","year":"2025","journal-title":"Eur. Heart J."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/15\/2338\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:05:10Z","timestamp":1785132310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/15\/2338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,26]]},"references-count":115,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["diagnostics16152338"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16152338","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,26]]}}}